Amgen’s Playing To Its R&D Strengths, Which No Longer Include Neuroscience

 
• By Mandy Jackson
  
Unrecognizable male scientist is plugging a microscopy app into a brain study interface. Science concept for biosciences, molecular engineering, bioengineering, pharmacogenomics, pharmacogenetics. - Image
180 Amgen jobs will be cut as the company ends early neuroscience R&D. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category